Characterization of plasma and lung concentrations after ceftiofur sodium and tilmicosin phosphate administered subcutaneously to mice.
Brown
S A
SA
Animal Health Drug Metabolism, Upjohn Company, Kalamazoo, ML 49001, USA.
Deleeuw
N R
NR
Stahl
G L
GL
Roof
R D
RD
D000818:Animals; D000900:Anti-Bacterial Agents / Q000008:administration & dosage / Q000097:blood / Q000493:pharmacokinetics*; D002511:Cephalosporins / Q000008:administration & dosage / Q000097:blood / Q000493:pharmacokinetics*; D007279:Injections, Subcutaneous / Q000662:veterinary; D008168:Lung / Q000378:metabolism*; D018942:Macrolides; D008297:Male; D051379:Mice; D010477:Perfusion; D014018:Tissue Distribution; D015645:Tylosin / Q000008:administration & dosage / Q000031:analogs & derivatives* / Q000097:blood / Q000493:pharmacokinetics
D000900:Anti-Bacterial Agents; D002511:Cephalosporins; D018942:Macrolides; C053503:ceftiofur; C052319:tilmicosin; D015645:Tylosin